A role of Gab2 association in Flt3 ITD mediated Stat5 phosphorylation and cell survival

British Journal of Haematology

Volumn 146, Issue 2, 2009, Pages 193-202

  Masson, Kristina ^a   Liu, Tao ^a   Khan, Rasheed ^a   Sun, Jianmin ^a   Rönnstrand, Lars ^a  

^a Malmö University Hospital   (Sweden)

Author keywords

Acute myeloid leukaemia; Flt3 ITD; Gab2; Stat5; Survival

Indexed keywords

CD135 ANTIGEN; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; STAT PROTEIN;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BINDING SITES; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; FMS-LIKE TYROSINE KINASE 3; HUMANS; LEUKEMIA, MYELOID, ACUTE; MUTATION; PHOSPHORYLATION; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; TUMOR CELLS, CULTURED; TYROSINE;

EID: 67650001509     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2009.07725.x     Document Type: Article

References (43)

1. Arnaud, M., Crouin, C., Deon, C., Loyaux, D. Bertoglio, J. (2004) Phosphorylation of Grb2-associated binder 2 on serine 623 by ERK MAPK regulates its association with the phosphatase SHP-2 and decreases STAT5 activation. Journal of Immunology, 173, 3962 3971. (Pubitemid 39280760)
2. Brockdorff, J.L., Gu, H., Mustelin, T., Kaltoft, K., Geisler, C., Röpke, C. Ødum, N. (2001) Gab2 is phosphorylated on tyrosine upon interleukin-2/interleukin-15 stimulation in mycosis-fungoides-derived tumor T cells and associates inducibly with SHP-2 and Stat5a. Experimental and Clinical Immunogenetics, 18, 86 95. (Pubitemid 32429673)
3. Bunting, K.D. (2007) STAT5 signaling in normal and pathologic hematopoiesis. Frontiers in Bioscience, 12, 2807 2820.
4. Chillón, M.C., Fernández, C., García-Sanz, R., Balanzategui, A., Ramos, F., Fernández-Calvo, J., González, M. Miguel, J.F. (2004) FLT3-activating mutations are associated with poor prognostic features in AML at diagnosis but they are not an independent prognostic factor. The Hematology Journal, 5, 239 246. (Pubitemid 38931330)
5. Chin, H., Arai, A., Wakao, H., Kamiyama, R., Miyasaka, N. Miura, O. (1998) Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway. Blood, 91, 3734 3745. (Pubitemid 28225741)
6. Choudhary, C., Schwäble, J., Brandts, C., Tickenbrock, L., Sargin, B., Kindler, T., Fischer, T., Berdel, W.E., Müller-Tidow, C. Serve, H. (2005) AML-associated Flt3 kinase domain mutations show signal transduction differences compared with Flt3 ITD mutations. Blood, 106, 265 273. (Pubitemid 40967202)
7. Choudhary, C., Brandts, C., Schwäble, J., Tickenbrock, L., Sargin, B., Ueker, A., Böhmer, F.D., Berdel, W.E., Müller-Tidow, C. Serve, H. (2007) Activation mechanisms of STAT5 by oncogenic Flt3-ITD. Blood, 110, 370 374. (Pubitemid 47026856)
8. Dumon, S., Santos, S.C., Debierre-Grockiego, F., Gouilleux-Gruart, V., Cocault, L., Boucheron, C., Mollat, P., Gisselbrecht, S. Gouilleux, F. (1999) IL-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line. Oncogene, 18, 4191 4199. (Pubitemid 29377850)
9. Gilliland, D.G. Griffin, J.D. (2002) The roles of FLT3 in hematopoiesis and leukemia. Blood, 100, 1532 1542. (Pubitemid 34925124)
10. Griffith, J., Black, J., Faerman, C., Swenson, L., Wynn, M., Lu, F., Lippke, J. Saxena, K. (2004) The structural basis for autoinhibition of FLT3 by the juxtamembrane domain. Molecular Cell, 13, 169 178. (Pubitemid 38183264)
11. Harir, N., Pecquet, C., Kerenyi, M., Sonneck, K., Kovacic, B., Nyga, R., Brevet, M., Dhennin, I., Gouilleux-Gruart, V., Beug, H., Valent, P., Lassoued, K., Moriggl, R. Gouilleux, F. (2007) Constitutive activation of Stat5 promotes its cytoplasmic localization and association with PI3-kinase in myeloid leukemias. Blood, 109, 1678 1686. (Pubitemid 46239602)
12. Hayakawa, F. Naoe, T. (2006) SFK-STAT pathway: an alternative and important way to malignancies. Annals of the New York Academy of Sciences, 1086, 213 222. (Pubitemid 47084370)
13. Hayakawa, F., Towatari, M., Kiyoi, H., Tanimoto, M., Kitamura, T., Saito, H. Naoe, T. (2000) Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines. Oncogene, 19, 624 631. (Pubitemid 30102913)
14. Heiss, E., Masson, K., Sundberg, C., Pedersen, M., Sun, J., Bengtsson, S. Rönnstrand, L. (2006) Identification of Y589 and Y599 in the juxtamembrane domain of Flt3 as ligand-induced autophosphorylation sites involved in binding of Src family kinases and the protein tyrosine phosphatase SHP2. Blood, 108, 1542 1550. (Pubitemid 44316119)
15. Holgado-Madruga, M., Moscatello, D.K., Emlet, D.R., Dieterich, R. Wong, A.J. (1997) Grb2-associated binder-1 mediates phosphatidylinositol 3-kinase activation and the promotion of cell survival by nerve growth factor. Proceedings of the National Academy of Sciences of the United States of America, 94, 12419 12424. (Pubitemid 27492543)
16. Khan, R., Schmidt-Mende, J., Karimi, M., Gogvadze, V., Hassan, M., Ekström, T.J., Zhivotovsky, B. Hellström-Lindberg, E. (2008) Hypomethylation and apoptosis in 5-azacytidine-treated myeloid cells. Experimental Hematology, 36, 149 157.
17. Kiyoi, H., Ohno, R., Ueda, R., Saito, H. Naoe, T. (2002) Mechanism of constitutive activation of FLT3 with internal tandem duplication in the juxtamembrane domain. Oncogene, 21, 2555 2563. (Pubitemid 34438108)
18. Kong, M., Mounier, C., Wu, J. Posner, B.I. (2000) Epidermal growth factor-induced phosphatidylinositol 3-kinase activation and DNA synthesis. Identification of Grb2-associated binder 2 as the major mediator in rat hepatocytes. Journal of Biological Chemistry, 275, 36035 36042. (Pubitemid 30841147)
19. Lennartsson, J., Blume-Jensen, P., Hermanson, M., Pontén, E., Carlberg, M. Rönnstrand, L. (1999) Phosphorylation of Shc by Src family kinases is necessary for stem cell factor receptor/c-kit mediated activation of the Ras/MAP kinase pathway and c-fos induction. Oncogene, 18, 5546 5553. (Pubitemid 29481501)
20. Liu, Y., Jenkins, B., Shin, J.L. Rohrschneider, L.R. (2001) Scaffolding protein Gab2 mediates differentiation signaling downstream of Fms receptor tyrosine kinase. Molecular and Cellular Biology, 21, 3047 3056. (Pubitemid 32298372)
21. Maroc, N., Rottapel, R., Rosnet, O., Marchetto, S., Lavezzi, C., Mannoni, P., Birnbaum, D. Dubreuil, P. (1993) Biochemical characterization and analysis of the transforming potential of the FLT3/FLK2 receptor tyrosine kinase. Oncogene, 8, 909 918.
22. Minami, Y., Yamamoto, K., Kiyoi, H., Ueda, R., Saito, H. Naoe, T. (2003) Different antiapoptotic pathways between wild-type and mutated FLT3: insights into therapeutic targets in leukemia. Blood, 102, 2969 2975. (Pubitemid 37248872)
23. Mizuki, M., Fenski, R., Halfter, H., Matsumura, I., Schmidt, R., Müller, C., Grüning, W., Kratz-Albers, K., Serve, S., Steur, C., Büchner, T., Kienast, J., Kanakura, Y., Berdel, W.E. Serve, H. (2000) Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways. Blood, 96, 3907 3914.
24. Moriggl, R., Topham, D.J., Teglund, S., Sexl, V., McKay, C., Wang, D., Hoffmeyer, A., van Deursen, J., Sangster, M.Y., Bunting, K.D., Grosveld, G.C. Ihle, J.N. (1999) Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. Immunity, 10, 249 259. (Pubitemid 29115630)
25. Ni, S., Zhao, C., Feng, G.S., Paulson, R.F. Correll, P.H. (2007) A novel Stat3 binding motif in Gab2 mediates transformation of primary hematopoietic cells by the Stk/Ron receptor tyrosine kinase in response to Friend virus infection. Molecular and Cellular Biology, 27, 3708 3715. (Pubitemid 46726178)
26. Nosaka, T., Kawashima, T., Misawa, K., Ikuta, K., Mui, A.L. Kitamura, T. (1999) STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells. EMBO Journal, 18, 4754 4765. (Pubitemid 29415529)
27. Nyga, R., Pecquet, C., Harir, N., Gu, H., Dhennin-Duthille, I., Regnier, A., Gouilleux-Gruart, V., Lassoued, K. Gouilleux, F. (2005) Activated STAT5 proteins induce activation of the PI 3-kinase/Akt and Ras/MAPK pathways via the Gab2 scaffolding adapter. Biochemical Journal, 390, 359 366. (Pubitemid 41192263)
28. Rocnik, J.L., Okabe, R., Yu, J.C., Lee, B.H., Giese, N., Schenkein, D.P. Gilliland, D.G. (2006) Roles of tyrosine 589 and 591 in STAT5 activation and transformation mediated by FLT3-ITD. Blood, 108, 1339 1345. (Pubitemid 44232034)
29. Rosa Santos, S.C., Dumon, S., Mayeux, P., Gisselbrecht, S. Gouilleux, F. (2000) Cooperation between STAT5 and phosphatidylinositol 3-kinase in the IL-3-dependent survival of a bone marrow derived cell line. Oncogene, 19, 1164 1172. (Pubitemid 30157546)
30. Santos, S.C., Lacronique, V., Bouchaert, I., Monni, R., Bernard, O., Gisselbrecht, S. Gouilleux, F. (2001) Constitutively active STAT5 variants induce growth and survival of hematopoietic cells through a PI 3-kinase/Akt dependent pathway. Oncogene, 20, 2080 2090. (Pubitemid 32424002)
31. Sattler, M., Mohi, M.G., Pride, Y.B., Quinnan, L.R., Malouf, N.A., Podar, K., Gesbert, F., Iwasaki, H., Li, S., Van Etten, R.A., Gu, H., Griffin, J.D. Neel, B.G. (2002) Critical role for Gab2 in transformation by BCR/ABL. Cancer Cell, 1, 479 492. (Pubitemid 41039128)
32. Songyang, Z., Shoelson, S.E., McGlade, J., Olivier, P., Pawson, T., Bustelo, X.R., Barbacid, M., Sabe, H., Hanafusa, H., Yi, T., Ren, R., Baltimore, D., Ratnofsky, S., Feldman, R.A. Cantley, L.C. (1994) Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav. Molecular and Cellular Biology, 14, 2777 2785.
33. Spiekermann, K., Bagrintseva, K., Schwab, R., Schmieja, K. Hiddemann, W. (2003) Overexpression and constitutive activation of FLT3 induces STAT5 activation in primary acute myeloid leukemia blast cells. Clinical Cancer Research, 9, 2140 2150. (Pubitemid 36687636)
34. Stirewalt, D.L. Radich, J.P. (2003) The role of FLT3 in haematopoietic malignancies. Nature Reviews. Cancer, 3, 650 665. (Pubitemid 37328820)
35. Sun, J., Pedersen, M., Bengtsson, S. Rönnstrand, L. (2007) Grb2 mediates negative regulation of stem cell factor receptor/c-Kit signaling by recruitment of Cbl. Experimental Cell Research, 313, 3935 3942. (Pubitemid 47561898)
36. Sun, J., Pedersen, M. Rönnstrand, L. (2008) Gab2 is involved in differential phosphoinositide 3-kinase signaling by two splice forms of c-Kit. Journal of Biological Chemistry, 283, 27444 27451.
37. Voytyuk, O., Lennartsson, J., Mogi, A., Caruana, G., Courtneidge, S., Ashman, L.K. Rönnstrand, L. (2003) Src family kinases are involved in the differential signaling from two splice forms of c-Kit. Journal of Biological Chemistry, 278, 9159 9166. (Pubitemid 36800397)
38. Yanada, M., Matsuo, K., Suzuki, T., Kiyoi, H. Naoe, T. (2005) Prognostic significance of FLT3 internal tandem duplication and tyrosine kinase domain mutations for acute myeloid leukemia: a meta-analysis. Leukemia, 19, 1345 1349. (Pubitemid 41136326)
39. Zatkova, A., Schoch, C., Speleman, F., Poppe, B., Mannhalter, C., Fonatsch, C. Wimmer, K. (2006) GAB2 is a novel target of 11q amplification in AML/MDS. Genes, Chromosomes and Cancer, 45, 798 807. (Pubitemid 44182438)
40. Zhang, S. Broxmeyer, H.E. (1999) p85 subunit of PI3 kinase does not bind to human Flt3 receptor, but associates with SHP2, SHIP, and a tyrosine-phosphorylated 100-kDa protein in Flt3 ligand-stimulated hematopoietic cells. Biochemical and Biophysical Research Communications, 254, 440 445. (Pubitemid 29290419)
41. Zhang, S. Broxmeyer, H.E. (2000) Flt3 ligand induces tyrosine phosphorylation of gab1 and gab2 and their association with shp-2, grb2, and PI3 kinase. Biochemical and Biophysical Research Communications, 277, 195 199. (Pubitemid 30796361)
42. Zhang, S., Mantel, C. Broxmeyer, H.E. (1999) Flt3 signaling involves tyrosyl-phosphorylation of SHP-2 and SHIP and their association with Grb2 and Shc in Baf3/Flt3 cells. Journal of Leukocyte Biology, 65, 372 380. (Pubitemid 29109711)
43. Zhang, Y., Diaz-Flores, E., Li, G., Wang, Z., Kang, Z., Haviernikova, E., Rowe, S., Qu, C.K., Tse, W., Shannon, K.M. Bunting, K.D. (2007) Abnormal hematopoiesis in Gab2 mutant mice. Blood, 110, 116 124. (Pubitemid 47026826)